Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.34% Nasdaq Up0.16%

Northwest Biotherapeutics, Inc. (NWBO)

-NasdaqCM

3.67 Down 0.03(0.81%) 4:00PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue 772   10   10  
Cost of Revenue -   -   -  
Gross Profit 772   10   10  
Operating Expenses
Research Development28,908  13,452  9,899  
Selling General and Administrative15,675  13,335  5,463  
Non Recurring -   -   -  
Others14  10  2  
Total Operating Expenses -   -   -  
Operating Income or Loss (43,825) (26,787) (15,354)
Income from Continuing Operations
Total Other Income/Expenses Net(10,053)1,605  (4,130)
Earnings Before Interest And Taxes(53,878)(25,182)(19,484)
Interest Expense13,442  7,648  7,884  
Income Before Tax(67,320)(32,830)(27,368)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(67,320)(32,830)(27,368)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (67,320) (32,830) (27,368)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (67,320) (32,830) (27,368)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.